Aspiration & Biopsy Needles Market by Product (Aspiration Needle, CNB, VAB), Application (Breast, Lung, Bone Cancer), Procedure (Image-guided (Ultrasound, MRI, Stereotactic), Non-image-guided), End user (Hospital, ASC, Academia) - Global Forecasts to 2027
The global aspiration and biopsy needles market is valued at an estimated USD 879 million in 2021 and is projected to reach USD 1,303 million by 2027, at a CAGR of 6.8%. The adoption of aspiration and biopsy needles is growing across major healthcare markets owing to the increasing incidence of cancer and the rising patient preference for minimally invasive diagnostic procedures.
“The Biopsy Needles segment is expected to witness the highest growth in the aspiration and biopsy needles market during the forecast period.”
On the basis of product, the aspiration and biopsy needles market is segmented into biopsy and aspiration needles. The biopsy needles segment is estimated to grow at the highest CAGR during the forecast period owing to its growing adoption among various healthcare facilities and due to the rising prevalence of cancer.
“The Hospitals segment is expected to witness the highest growth during the forecast period.”
On the basis of end user, the aspiration and biopsy needles market is segmented into hospitals & surgical centers, ambulatory care centers, diagnostic clinics & pathology laboratories, and research & academic institutes. The hospitals & surgical centers segment is estimated to grow at the highest rate during the forecast period due to the rising prevalence of cancer, increasing preference for minimally invasive procedures in hospital settings, and developing healthcare infrastructure in emerging countries.
“On the basis of application, the breast cancer segment is expected to hold the largest share of the market in 2021.”
On the basis of application, the aspiration and biopsy needles market is segmented by tumor/cancer applications (breast, lung, colorectal, prostate, kidney, bone & bone marrow, and other cancers), wound applications, and other applications. The breast cancer segment accounted for the largest share of the aspiration and biopsy needles market in 2020. The large share of this segment is mainly attributed to the rising prevalence of breast cancer as well as growing awareness about the disease and increasing research activity pertaining to breast screening and diagnosis
“Image-guided procedure segment is expected to witness the highest growth during the forecast period.”
On the basis of procedure, the aspiration and biopsy needles market is segmented into image-guided procedures and nonimage-guided procedures. The image-guided procedure segment is projected to grow at the highest CAGR during the forecast period due to the rising preference for minimally invasive biopsy and aspiration procedures.
“Asia Pacific is expected to grow at the highest CAGR in the market, by region, during the forecast period.”
Emerging economies such as India, China, and South Korea are offering high-growth opportunities for market players. The Asia Pacific market is expected to grow at the highest CAGR during the forecast period. Increasing initiatives by government for the cancer diagnostics and screening, rising research activity, and the high incidence of cancer in key APAC countries such as India and China are the major factors driving the growth of this regional market.
Breakdown of supply-side primary interviews:
CONMED Corporation (US), Stryker Corporation (US), Medtronic plc (Ireland), Olympus Corporation (Japan), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Group Incorporated (US), Argon Medical Devices (US), INRAD Inc. (US), Somatex Medical Technologies GmbH (Germany), Cardinal Health (US), Remington Medical (US), Hakko Co., Ltd. (Japan), Merit Medical Systems (US), and Ranfac Corporation (US), among others.
Research Coverage
This report studies the aspiration and biopsy needles market by product, application, procedure, end user, and region. It also covers factors affecting market growth, analyzes various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their individual growth trends and forecasts the size of market segments with respect to key regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
“The Biopsy Needles segment is expected to witness the highest growth in the aspiration and biopsy needles market during the forecast period.”
On the basis of product, the aspiration and biopsy needles market is segmented into biopsy and aspiration needles. The biopsy needles segment is estimated to grow at the highest CAGR during the forecast period owing to its growing adoption among various healthcare facilities and due to the rising prevalence of cancer.
“The Hospitals segment is expected to witness the highest growth during the forecast period.”
On the basis of end user, the aspiration and biopsy needles market is segmented into hospitals & surgical centers, ambulatory care centers, diagnostic clinics & pathology laboratories, and research & academic institutes. The hospitals & surgical centers segment is estimated to grow at the highest rate during the forecast period due to the rising prevalence of cancer, increasing preference for minimally invasive procedures in hospital settings, and developing healthcare infrastructure in emerging countries.
“On the basis of application, the breast cancer segment is expected to hold the largest share of the market in 2021.”
On the basis of application, the aspiration and biopsy needles market is segmented by tumor/cancer applications (breast, lung, colorectal, prostate, kidney, bone & bone marrow, and other cancers), wound applications, and other applications. The breast cancer segment accounted for the largest share of the aspiration and biopsy needles market in 2020. The large share of this segment is mainly attributed to the rising prevalence of breast cancer as well as growing awareness about the disease and increasing research activity pertaining to breast screening and diagnosis
“Image-guided procedure segment is expected to witness the highest growth during the forecast period.”
On the basis of procedure, the aspiration and biopsy needles market is segmented into image-guided procedures and nonimage-guided procedures. The image-guided procedure segment is projected to grow at the highest CAGR during the forecast period due to the rising preference for minimally invasive biopsy and aspiration procedures.
“Asia Pacific is expected to grow at the highest CAGR in the market, by region, during the forecast period.”
Emerging economies such as India, China, and South Korea are offering high-growth opportunities for market players. The Asia Pacific market is expected to grow at the highest CAGR during the forecast period. Increasing initiatives by government for the cancer diagnostics and screening, rising research activity, and the high incidence of cancer in key APAC countries such as India and China are the major factors driving the growth of this regional market.
Breakdown of supply-side primary interviews:
- By Company Type: Tier 1 - 48%, Tier 2 - 36%, and Tier 3 - 16%
- By Designation: C-level - 10%, Director-level - 14%, and Others - 76%
- By Region: North America - 40%, Europe - 32%, APAC - 20%, and RoW - 8%
CONMED Corporation (US), Stryker Corporation (US), Medtronic plc (Ireland), Olympus Corporation (Japan), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Group Incorporated (US), Argon Medical Devices (US), INRAD Inc. (US), Somatex Medical Technologies GmbH (Germany), Cardinal Health (US), Remington Medical (US), Hakko Co., Ltd. (Japan), Merit Medical Systems (US), and Ranfac Corporation (US), among others.
Research Coverage
This report studies the aspiration and biopsy needles market by product, application, procedure, end user, and region. It also covers factors affecting market growth, analyzes various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their individual growth trends and forecasts the size of market segments with respect to key regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the aspiration and biopsy needles market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the aspiration and biopsy needles market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the aspiration and biopsy needles market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKETS COVERED
FIGURE 1 ASPIRATION AND BIOPSY NEEDLES MARKET SEGMENTATION
1.4 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH DESIGN
FIGURE 2 ASPIRATION AND BIOPSY NEEDLES MARKET: RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Secondary sources
2.2.2 PRIMARY DATA
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET ESTIMATION METHODOLOGY
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.3.1 TOP-DOWN AND BOTTOM-UP APPROACHES FOR MARKET ESTIMATION
2.3.2 REVENUE MAPPING-BASED MARKET ESTIMATION
FIGURE 5 ASPIRATION AND BIOPSY NEEDLES MARKET: REVENUE MAPPING-BASED MARKET ESTIMATION APPROACH
FIGURE 6 ASPIRATION AND BIOPSY NEEDLES MARKET: TOP-DOWN APPROACH
2.3.3 PRIMARY RESEARCH VALIDATION
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 MARKET DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
FIGURE 8 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2021 VS. 2027 (USD MILLION)
FIGURE 9 ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2021 VS. 2027 (USD MILLION)
FIGURE 10 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2021 VS. 2027 (USD MILLION)
FIGURE 11 ASPIRATION AND BIOPSY NEEDLES MARKET SHARE, BY END USER, 2021 VS. 2027
FIGURE 12 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION
4 PREMIUM INSIGHTS
4.1 ASPIRATION AND BIOPSY NEEDLES MARKET OVERVIEW
FIGURE 13 INCREASING PREVALENCE OF CANCER ACROSS THE GLOBE IS DRIVING MARKET GROWTH
4.2 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2021 VS. 2027 (USD MILLION)
FIGURE 14 BIOPSY NEEDLES SEGMENT TO HOLD MAJOR SHARE OF THE NORTH AMERICAN MARKET
4.3 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2021 VS. 2027 (USD MILLION)
FIGURE 15 ULTRASOUND-GUIDED PROCEDURES SEGMENT TO DOMINATE
THE ASIA PACIFIC MARKET
4.4 MEA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2021 VS. 2027 (USD MILLION)
FIGURE 16 BREAST CANCER APPLICATIONS SEGMENT TO DOMINATE THE MEA MARKET
4.5 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2021 VS. 2027 (USD MILLION)
FIGURE 17 HOSPITALS & SURGICAL CENTERS FORMED THE LARGEST END-USER SEGMENT IN THE EUROPEAN MARKET
4.6 GEOGRAPHIC SNAPSHOT OF THE ASPIRATION AND BIOPSY NEEDLES MARKET
FIGURE 18 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
FIGURE 19 ASPIRATION AND BIOPSY NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.1.1 DRIVERS
5.1.1.1 Rising prevalence of cancer
FIGURE 20 NUMBER OF NEW CANCER CASES (GLOBAL), 2018 VS. 2020
5.1.1.2 Cancer awareness initiatives undertaken by governments and global health organizations
5.1.1.3 Increasing preference for minimally invasive biopsies
5.1.2 RESTRAINTS
5.1.2.1 Risk of infections associated with the use of aspiration and biopsy needles
5.1.2.2 Product recalls
TABLE 2 RECENT PRODUCT RECALLS BY FDA
5.1.3 OPPORTUNITIES
5.1.3.1 Emerging economies
5.1.4 CHALLENGES
5.1.4.1 Underdeveloped healthcare infrastructure and dearth of well-trained radiologists and oncologists
5.2 INDUSTRY TRENDS
5.2.1 EMERGENCE OF LIQUID BIOPSY
5.3 VALUE CHAIN ANALYSIS
FIGURE 21 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING
THE MANUFACTURING PHASE
5.4 REGULATORY ANALYSIS
5.4.1 NORTH AMERICA
5.4.1.1 US
TABLE 3 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.1.2 Canada
TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 22 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.4.2 EUROPE
FIGURE 23 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
5.4.3 ASIA PACIFIC
5.4.3.1 Japan
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.4.3.2 China
TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.4.3.3 India
5.5 PORTER’S FIVE FORCES ANALYSIS
TABLE 8 ASPIRATION AND BIOPSY NEEDLES MARKET: PORTER’S FIVE FORCES ANALYSIS
5.5.1 THREAT OF NEW ENTRANTS
5.5.2 THREAT OF SUBSTITUTES
5.5.3 BARGAINING POWER OF SUPPLIERS
5.5.4 BARGAINING POWER OF BUYERS
5.5.5 DEGREE OF COMPETITION
5.6 IMPACT OF COVID-19 ON THE ASPIRATION AND BIOPSY NEEDLES MARKET
5.7 ECOSYSTEM COVERAGE: ASPIRATION AND BIOPSY NEEDLES MARKET
5.8 TRADE ANALYSIS
5.8.1 TRADE ANALYSIS FOR BIOPSY NEEDLES
TABLE 9 EXPORT DATA FOR BIOPSY NEEDLES, BY COUNTRY, 2018–2020 (USD MILLION)
TABLE 10 IMPORT DATA FOR BIOPSY NEEDLES, BY COUNTRY, 2018–2020 (USD MILLION)
5.9 TECHNOLOGY ANALYSIS
5.10 PATENT ANALYSIS
FIGURE 24 TOP 10 PATENT APPLICANTS FOR ASPIRATION AND BIOPSY NEEDLES (DECEMBER 2021)
FIGURE 25 PATENT APPLICATIONS FOR ASPIRATION AND BIOPSY NEEDLES
(JANUARY 2011 TO DECEMBER 2021)
FIGURE 26 TOP 10 PATENT APPLICANTS FOR BIOPSY NEEDLES
(JANUARY 2011 TO DECEMBER 2021)
FIGURE 27 PATENT APPLICATIONS FOR ASPIRATION NEEDLES
(JANUARY 2011 TO DECEMBER 2021)
6 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 11 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
6.2 BIOPSY NEEDLES
TABLE 12 BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 13 BIOPSY NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION)
6.2.1 BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 14 BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
6.2.2 BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 15 BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
6.2.3 BIOPSY NEEDLES MARKET SPLIT, BY END USER, 2019–2027 (USD MILLION)
TABLE 16 BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
6.2.4 CORE BIOPSY NEEDLES
6.2.4.1 Core biopsy needles are widely used for sample collection in most prevalent cancer types
TABLE 17 CORE BIOPSY NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION)
6.2.5 CORE BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 18 CORE BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
6.2.6 CORE BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 19 CORE BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
6.2.7 CORE BIOPSY NEEDLES MARKET SPLIT, BY END USER, 2019–2027 (USD MILLION)
TABLE 20 CORE BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
6.2.8 VACUUM-ASSISTED BIOPSY NEEDLES
6.2.8.1 High-volume sampling and greater specificity of VAB procedures to drive the growth of this market segment
TABLE 21 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION)
6.2.9 VACUUM-ASSISTED BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 22 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
6.2.10 VACUUM-ASSISTED BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 23 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
6.2.11 VACUUM-ASSISTED BIOPSY NEEDLES MARKET SPLIT, BY END USER, 2019–2027 (USD MILLION)
TABLE 24 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
6.3 ASPIRATION NEEDLES
6.3.1 ASPIRATION NEEDLES ARE ESTIMATED TO ACCOUNT FOR A SMALLER SHARE OF THE MARKET
TABLE 25 ASPIRATION NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION)
6.3.2 ASPIRATION NEEDLES MARKET SPLIT, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 26 ASPIRATION NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
6.3.3 ASPIRATION NEEDLES MARKET SPLIT, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 27 ASPIRATION NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
6.3.4 ASPIRATION NEEDLES MARKET SPLIT, BY END USER, 2019–2027 (USD MILLION)
TABLE 28 ASPIRATION NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
7 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE
7.1 INTRODUCTION
TABLE 29 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
7.2 IMAGE-GUIDED PROCEDURES
TABLE 30 ASPIRATION AND BIOPSY NEEDLES MARKET FOR IMAGE-GUIDED PROCEDURES, BY TYPE, 2019–2027 (USD MILLION)
7.2.1 ULTRASOUND-GUIDED PROCEDURES
7.2.1.1 Ultrasound imaging is the preferred imaging standard for most common cancer types
TABLE 31 ASPIRATION AND BIOPSY NEEDLES MARKET FOR ULTRASOUND-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION)
7.2.2 STEREOTACTIC PROCEDURES
7.2.2.1 Stereotactic procedures are still considered the global standard in biopsies
TABLE 32 ASPIRATION AND BIOPSY NEEDLES MARKET FOR STEREOTACTIC PROCEDURES, BY REGION, 2019–2027 (USD MILLION)
7.2.3 CT-GUIDED PROCEDURES
7.2.3.1 CT imaging is the preferred imaging standard for lung and liver cancers
TABLE 33 ASPIRATION AND BIOPSY NEEDLES MARKET FOR CT-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION)
7.2.4 MRI-GUIDED PROCEDURES
7.2.4.1 MRI imaging is the preferred imaging standard for several common cancer types
TABLE 34 ASPIRATION AND BIOPSY NEEDLES MARKET FOR MRI-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION)
7.2.5 OTHER IMAGE-GUIDED PROCEDURES
TABLE 35 ASPIRATION AND BIOPSY NEEDLES MARKET FOR OTHER IMAGE-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION)
7.3 NON-IMAGE-GUIDED PROCEDURES
7.3.1 NON-IMAGE-GUIDED PROCEDURES SEGMENT TO ACCOUNT FOR A SMALLER SHARE OF THE MARKET
TABLE 36 ASPIRATION AND BIOPSY NEEDLES MARKET FOR NON-IMAGE-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION)
8 ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 37 ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
8.2 TUMOR/CANCER APPLICATIONS
TABLE 38 ASPIRATION AND BIOPSY NEEDLES MARKET FOR TUMOR/CANCER APPLICATIONS, BY TYPE, 2019–2027 (USD MILLION)
8.2.1 BREAST CANCER
8.2.1.1 Increasing awareness of breast cancer to drive the growth of this market segment
TABLE 39 ASPIRATION AND BIOPSY NEEDLES MARKET FOR BREAST CANCER, BY REGION, 2019–2027 (USD MILLION)
8.2.2 LUNG CANCER
8.2.2.1 Growing prevalence of lung cancer to support the growth of this market segment
TABLE 40 ASPIRATION AND BIOPSY NEEDLES MARKET FOR LUNG CANCER, BY REGION, 2019–2027 (USD MILLION)
8.2.3 COLORECTAL CANCER
8.2.3.1 Advancements in alternative diagnosis techniques to reduce
the adoption of colorectal biopsy needles
TABLE 41 ASPIRATION AND BIOPSY NEEDLES MARKET FOR COLORECTAL CANCER, BY REGION, 2019–2027 (USD MILLION)
8.2.4 PROSTATE CANCER
8.2.4.1 Availability of funds for prostate cancer research by different government authorities to support the growth of this market segment
TABLE 42 ASPIRATION AND BIOPSY NEEDLES MARKET FOR PROSTATE CANCER, BY REGION, 2019–2027 (USD MILLION)
8.2.5 KIDNEY CANCER
8.2.5.1 Rising prevalence of kidney cancer to support the growth of this market segment
TABLE 43 ASPIRATION AND BIOPSY NEEDLES MARKET FOR KIDNEY CANCER, BY REGION, 2019–2027 (USD MILLION)
8.2.6 BONE & BONE MARROW CANCER
8.2.6.1 Rising incidence of bone cancer to fuel the growth of this market segment
TABLE 44 ASPIRATION AND BIOPSY NEEDLES MARKET FOR BONE & BONE MARROW CANCER, BY REGION, 2019–2027 (USD MILLION)
8.2.7 OTHER CANCERS
TABLE 45 ASPIRATION AND BIOPSY NEEDLES MARKET FOR OTHER CANCERS, BY REGION, 2019–2027 (USD MILLION)
8.3 WOUND APPLICATIONS
8.3.1 THE DEMAND FOR WOUND BIOPSIES IS EXPECTED TO INCREASE WITH
THE INCREASE IN PREVALENCE OF DIABETIC FOOT ULCERS
TABLE 46 ASPIRATION AND BIOPSY NEEDLES MARKET FOR WOUND APPLICATIONS, BY REGION, 2019–2027 (USD MILLION)
8.4 OTHER APPLICATIONS
TABLE 47 ASPIRATION AND BIOPSY NEEDLES MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2027 (USD MILLION)
9 ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER
9.1 INTRODUCTION
TABLE 48 ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
9.2 HOSPITALS & SURGICAL CENTERS
9.2.1 HOSPITALS AND SURGICAL CENTERS ARE THE LARGEST END USERS OF ASPIRATION AND BIOPSY NEEDLES
TABLE 49 ASPIRATION AND BIOPSY NEEDLES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2019–2027 (USD MILLION)
9.3 AMBULATORY CARE CENTERS
9.3.1 PREFERENCE FOR NEEDLE BIOPSIES IN AMBULATORY CARE CENTERS IS INCREASING DUE TO ONE-DAY OUTPATIENT SURGERY TIMELINES
TABLE 50 ASPIRATION AND BIOPSY NEEDLES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2019–2027 (USD MILLION)
9.4 DIAGNOSTIC CLINICS & PATHOLOGY LABORATORIES
9.4.1 A MAJORITY OF SAMPLE DIAGNOSIS IS PERFORMED BY DIAGNOSTIC/PATHOLOGY LABORATORIES
TABLE 51 ASPIRATION AND BIOPSY NEEDLES MARKET FOR DIAGNOSTIC CLINICS & PATHOLOGY LABORATORIES, BY REGION, 2019–2027 (USD MILLION)
9.5 RESEARCH & ACADEMIC INSTITUTES
9.5.1 MARKET FOR BIOPSY NEEDLES IN RESEARCH & ACADEMIC INSTITUTES IS EXPECTED TO GROW WITH GROWTH IN CANCER RESEARCH
TABLE 52 ASPIRATION AND BIOPSY NEEDLES MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2019–2027 (USD MILLION)
10 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION
10.1 INTRODUCTION
TABLE 53 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION)
10.2 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT
TABLE 54 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 55 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 56 ASIA PACIFIC: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 57 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 58 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 59 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
10.2.1 CHINA
10.2.1.1 China is the largest market for aspiration and biopsy needles in APAC
TABLE 60 CHINA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 61 CHINA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.2.2 JAPAN
10.2.2.1 Japan is the second-largest market for aspiration and biopsy needles in APAC
TABLE 62 JAPAN: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 63 JAPAN: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.2.3 INDIA
10.2.3.1 Improving healthcare infrastructure to drive market growth in India
TABLE 64 INDIA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 65 INDIA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.2.4 SOUTH KOREA
10.2.4.1 Growing healthcare expenditure to drive market growth in
South Korea
TABLE 66 SOUTH KOREA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 67 SOUTH KOREA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.2.5 AUSTRALIA
10.2.5.1 Increasing prevalence of cancer to drive market growth in Australia
TABLE 68 AUSTRALIA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 69 AUSTRALIA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.2.6 REST OF ASIA PACIFIC
TABLE 70 ROAPAC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 71 ROAPAC: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.3 EUROPE
TABLE 72 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 73 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 74 EUROPE: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 75 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 76 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 77 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Higher per capita spending on healthcare and presence of notable players to drive market growth in Germany
TABLE 78 GERMANY: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 79 GERMANY: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 Increasing prevalence of cancer to drive market growth in France
TABLE 80 FRANCE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 81 FRANCE: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.3.3 UK
10.3.3.1 Higher per capita spending on healthcare and the presence of notable players are expected to support market growth in the UK
TABLE 82 UK: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 83 UK: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Increasing geriatric population to drive market growth in Italy
TABLE 84 ITALY: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 85 ITALY: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Growing prevalence of cancer to drive market growth in Spain
TABLE 86 SPAIN: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 87 SPAIN: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 88 ROE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 89 ROE: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.4 NORTH AMERICA
FIGURE 29 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT
TABLE 90 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 91 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 92 NORTH AMERICA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 93 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 94 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 95 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
10.4.1 US
10.4.1.1 The US dominates the North American aspiration and biopsy needles market
TABLE 96 US: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 97 US: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.4.2 CANADA
10.4.2.1 Growing incidence of cancer to drive market growth in Canada
TABLE 98 CANADA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 99 CANADA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.5 LATIN AMERICA
TABLE 100 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 101 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 102 LATIN AMERICA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 103 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 104 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 105 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Brazil is the largest market for aspiration and biopsy needles
in LATAM
TABLE 106 BRAZIL: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 107 BRAZIL: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Increasing healthcare spending to drive market growth in Mexico
TABLE 108 MEXICO: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 109 MEXICO: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 110 ROLA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 111 ROLA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH IN MEA
TABLE 112 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 113 MIDDLE EAST & AFRICA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 114 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 115 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 116 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES
11.3 MARKET SHARE ANALYSIS: ASPIRATION AND BIOPSY NEEDLES MARKET, BY KEY PLAYER (2020)
FIGURE 30 BECTON, DICKINSON AND COMPANY HELD THE LEADING POSITION IN
THE ASPIRATION AND BIOPSY NEEDLES MARKET IN 2020
11.4 COMPANY EVALUATION QUADRANT FOR 25 MAJOR PLAYERS (2020)
11.4.1 STARS
11.4.2 EMERGING LEADERS
11.4.3 PERVASIVE PLAYERS
11.4.4 PARTICIPANTS
FIGURE 31 ASPIRATION AND BIOPSY NEEDLES MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
11.5 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2020)
11.5.1 PROGRESSIVE COMPANIES
11.5.2 RESPONSIVE COMPANIES
11.5.3 DYNAMIC COMPANIES
11.5.4 STARTING BLOCKS
FIGURE 32 ASPIRATION AND BIOPSY NEEDLES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS (2020)
11.6 COMPETITIVE BENCHMARKING
TABLE 117 APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ASPIRATION AND BIOPSY NEEDLES MARKET
TABLE 118 REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ASPIRATION AND BIOPSY NEEDLES MARKET
11.7 COMPETITIVE SCENARIO (2018–2021)
11.7.1 NEW PRODUCT LAUNCHES AND APPROVALS
11.7.2 DEALS
12 COMPANY PROFILES
12.1 INTRODUCTION
12.2 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.2.1 BECTON, DICKINSON AND COMPANY (BD)
TABLE 119 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 33 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
12.2.2 MERIT MEDICAL SYSTEMS
TABLE 120 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW
FIGURE 34 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2020)
12.2.3 COOK GROUP INCORPORATED
TABLE 121 COOK GROUP INCORPORATED: BUSINESS OVERVIEW
12.2.4 OLYMPUS CORPORATION
TABLE 122 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 35 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021)
12.2.5 MEDTRONIC, PLC
TABLE 123 MEDTRONIC, PLC: BUSINESS OVERVIEW
FIGURE 36 MEDTRONIC, PLC: COMPANY SNAPSHOT (2020)
12.2.6 ARGON MEDICAL DEVICES, INC.
TABLE 124 ARGON MEDICAL DEVICES, INC: BUSINESS OVERVIEW
12.2.7 BOSTON SCIENTIFIC CORPORATION
TABLE 125 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 37 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)
12.2.8 CARDINAL HEALTH, INC.
TABLE 126 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
FIGURE 38 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2021)
12.2.9 CONMED CORPORATION
TABLE 127 CONMED CORPORATION: BUSINESS OVERVIEW
FIGURE 39 CONMED CORPORATION: COMPANY SNAPSHOT (2020)
12.2.10 HAKKO CO., LTD.
TABLE 128 HAKKO CO., LTD.: BUSINESS OVERVIEW
12.2.11 INRAD INC.
TABLE 129 INRAD INC.: BUSINESS OVERVIEW
12.2.12 RANFAC CORPORATION
TABLE 130 RANFAC CORPORATION: BUSINESS OVERVIEW
12.2.13 REMINGTON MEDICAL INC.
TABLE 131 REMINGTON MEDICAL INC.: BUSINESS OVERVIEW
12.2.14 SOMATEX MEDICAL TECHNOLOGIES
TABLE 132 SOMATEX MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW
12.2.15 STRYKER CORPORATION
TABLE 133 STRYKER CORPORATION: BUSINESS OVERVIEW
FIGURE 40 STRYKER CORPORATION: COMPANY SNAPSHOT (2020)
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.3 OTHER PLAYERS
12.3.1 CREGANNA
12.3.2 STERYLAB SRL
12.3.3 DR. JAPAN CO., LTD.
12.3.4 DTR MEDICAL
12.3.5 ISCON SURGICALS LTD.
12.3.6 JOHNSON & JOHNSON MEDICAL DEVICES
12.3.7 SHANGHAI SA MEDICAL & PLASTIC INSTRUMENTS
12.3.8 MEDAX MEDICAL DEVICES
12.3.9 MEDITECH DEVICES
12.3.10 WELLGO MEDICAL PRODUCTS GMBH
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKETS COVERED
FIGURE 1 ASPIRATION AND BIOPSY NEEDLES MARKET SEGMENTATION
1.4 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH DESIGN
FIGURE 2 ASPIRATION AND BIOPSY NEEDLES MARKET: RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Secondary sources
2.2.2 PRIMARY DATA
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET ESTIMATION METHODOLOGY
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.3.1 TOP-DOWN AND BOTTOM-UP APPROACHES FOR MARKET ESTIMATION
2.3.2 REVENUE MAPPING-BASED MARKET ESTIMATION
FIGURE 5 ASPIRATION AND BIOPSY NEEDLES MARKET: REVENUE MAPPING-BASED MARKET ESTIMATION APPROACH
FIGURE 6 ASPIRATION AND BIOPSY NEEDLES MARKET: TOP-DOWN APPROACH
2.3.3 PRIMARY RESEARCH VALIDATION
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 MARKET DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
FIGURE 8 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2021 VS. 2027 (USD MILLION)
FIGURE 9 ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2021 VS. 2027 (USD MILLION)
FIGURE 10 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2021 VS. 2027 (USD MILLION)
FIGURE 11 ASPIRATION AND BIOPSY NEEDLES MARKET SHARE, BY END USER, 2021 VS. 2027
FIGURE 12 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION
4 PREMIUM INSIGHTS
4.1 ASPIRATION AND BIOPSY NEEDLES MARKET OVERVIEW
FIGURE 13 INCREASING PREVALENCE OF CANCER ACROSS THE GLOBE IS DRIVING MARKET GROWTH
4.2 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2021 VS. 2027 (USD MILLION)
FIGURE 14 BIOPSY NEEDLES SEGMENT TO HOLD MAJOR SHARE OF THE NORTH AMERICAN MARKET
4.3 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2021 VS. 2027 (USD MILLION)
FIGURE 15 ULTRASOUND-GUIDED PROCEDURES SEGMENT TO DOMINATE
THE ASIA PACIFIC MARKET
4.4 MEA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2021 VS. 2027 (USD MILLION)
FIGURE 16 BREAST CANCER APPLICATIONS SEGMENT TO DOMINATE THE MEA MARKET
4.5 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2021 VS. 2027 (USD MILLION)
FIGURE 17 HOSPITALS & SURGICAL CENTERS FORMED THE LARGEST END-USER SEGMENT IN THE EUROPEAN MARKET
4.6 GEOGRAPHIC SNAPSHOT OF THE ASPIRATION AND BIOPSY NEEDLES MARKET
FIGURE 18 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
FIGURE 19 ASPIRATION AND BIOPSY NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.1.1 DRIVERS
5.1.1.1 Rising prevalence of cancer
FIGURE 20 NUMBER OF NEW CANCER CASES (GLOBAL), 2018 VS. 2020
5.1.1.2 Cancer awareness initiatives undertaken by governments and global health organizations
5.1.1.3 Increasing preference for minimally invasive biopsies
5.1.2 RESTRAINTS
5.1.2.1 Risk of infections associated with the use of aspiration and biopsy needles
5.1.2.2 Product recalls
TABLE 2 RECENT PRODUCT RECALLS BY FDA
5.1.3 OPPORTUNITIES
5.1.3.1 Emerging economies
5.1.4 CHALLENGES
5.1.4.1 Underdeveloped healthcare infrastructure and dearth of well-trained radiologists and oncologists
5.2 INDUSTRY TRENDS
5.2.1 EMERGENCE OF LIQUID BIOPSY
5.3 VALUE CHAIN ANALYSIS
FIGURE 21 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING
THE MANUFACTURING PHASE
5.4 REGULATORY ANALYSIS
5.4.1 NORTH AMERICA
5.4.1.1 US
TABLE 3 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.1.2 Canada
TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 22 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.4.2 EUROPE
FIGURE 23 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
5.4.3 ASIA PACIFIC
5.4.3.1 Japan
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.4.3.2 China
TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.4.3.3 India
5.5 PORTER’S FIVE FORCES ANALYSIS
TABLE 8 ASPIRATION AND BIOPSY NEEDLES MARKET: PORTER’S FIVE FORCES ANALYSIS
5.5.1 THREAT OF NEW ENTRANTS
5.5.2 THREAT OF SUBSTITUTES
5.5.3 BARGAINING POWER OF SUPPLIERS
5.5.4 BARGAINING POWER OF BUYERS
5.5.5 DEGREE OF COMPETITION
5.6 IMPACT OF COVID-19 ON THE ASPIRATION AND BIOPSY NEEDLES MARKET
5.7 ECOSYSTEM COVERAGE: ASPIRATION AND BIOPSY NEEDLES MARKET
5.8 TRADE ANALYSIS
5.8.1 TRADE ANALYSIS FOR BIOPSY NEEDLES
TABLE 9 EXPORT DATA FOR BIOPSY NEEDLES, BY COUNTRY, 2018–2020 (USD MILLION)
TABLE 10 IMPORT DATA FOR BIOPSY NEEDLES, BY COUNTRY, 2018–2020 (USD MILLION)
5.9 TECHNOLOGY ANALYSIS
5.10 PATENT ANALYSIS
FIGURE 24 TOP 10 PATENT APPLICANTS FOR ASPIRATION AND BIOPSY NEEDLES (DECEMBER 2021)
FIGURE 25 PATENT APPLICATIONS FOR ASPIRATION AND BIOPSY NEEDLES
(JANUARY 2011 TO DECEMBER 2021)
FIGURE 26 TOP 10 PATENT APPLICANTS FOR BIOPSY NEEDLES
(JANUARY 2011 TO DECEMBER 2021)
FIGURE 27 PATENT APPLICATIONS FOR ASPIRATION NEEDLES
(JANUARY 2011 TO DECEMBER 2021)
6 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 11 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
6.2 BIOPSY NEEDLES
TABLE 12 BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 13 BIOPSY NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION)
6.2.1 BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 14 BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
6.2.2 BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 15 BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
6.2.3 BIOPSY NEEDLES MARKET SPLIT, BY END USER, 2019–2027 (USD MILLION)
TABLE 16 BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
6.2.4 CORE BIOPSY NEEDLES
6.2.4.1 Core biopsy needles are widely used for sample collection in most prevalent cancer types
TABLE 17 CORE BIOPSY NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION)
6.2.5 CORE BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 18 CORE BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
6.2.6 CORE BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 19 CORE BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
6.2.7 CORE BIOPSY NEEDLES MARKET SPLIT, BY END USER, 2019–2027 (USD MILLION)
TABLE 20 CORE BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
6.2.8 VACUUM-ASSISTED BIOPSY NEEDLES
6.2.8.1 High-volume sampling and greater specificity of VAB procedures to drive the growth of this market segment
TABLE 21 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION)
6.2.9 VACUUM-ASSISTED BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 22 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
6.2.10 VACUUM-ASSISTED BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 23 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
6.2.11 VACUUM-ASSISTED BIOPSY NEEDLES MARKET SPLIT, BY END USER, 2019–2027 (USD MILLION)
TABLE 24 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
6.3 ASPIRATION NEEDLES
6.3.1 ASPIRATION NEEDLES ARE ESTIMATED TO ACCOUNT FOR A SMALLER SHARE OF THE MARKET
TABLE 25 ASPIRATION NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION)
6.3.2 ASPIRATION NEEDLES MARKET SPLIT, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 26 ASPIRATION NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
6.3.3 ASPIRATION NEEDLES MARKET SPLIT, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 27 ASPIRATION NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
6.3.4 ASPIRATION NEEDLES MARKET SPLIT, BY END USER, 2019–2027 (USD MILLION)
TABLE 28 ASPIRATION NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
7 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE
7.1 INTRODUCTION
TABLE 29 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
7.2 IMAGE-GUIDED PROCEDURES
TABLE 30 ASPIRATION AND BIOPSY NEEDLES MARKET FOR IMAGE-GUIDED PROCEDURES, BY TYPE, 2019–2027 (USD MILLION)
7.2.1 ULTRASOUND-GUIDED PROCEDURES
7.2.1.1 Ultrasound imaging is the preferred imaging standard for most common cancer types
TABLE 31 ASPIRATION AND BIOPSY NEEDLES MARKET FOR ULTRASOUND-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION)
7.2.2 STEREOTACTIC PROCEDURES
7.2.2.1 Stereotactic procedures are still considered the global standard in biopsies
TABLE 32 ASPIRATION AND BIOPSY NEEDLES MARKET FOR STEREOTACTIC PROCEDURES, BY REGION, 2019–2027 (USD MILLION)
7.2.3 CT-GUIDED PROCEDURES
7.2.3.1 CT imaging is the preferred imaging standard for lung and liver cancers
TABLE 33 ASPIRATION AND BIOPSY NEEDLES MARKET FOR CT-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION)
7.2.4 MRI-GUIDED PROCEDURES
7.2.4.1 MRI imaging is the preferred imaging standard for several common cancer types
TABLE 34 ASPIRATION AND BIOPSY NEEDLES MARKET FOR MRI-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION)
7.2.5 OTHER IMAGE-GUIDED PROCEDURES
TABLE 35 ASPIRATION AND BIOPSY NEEDLES MARKET FOR OTHER IMAGE-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION)
7.3 NON-IMAGE-GUIDED PROCEDURES
7.3.1 NON-IMAGE-GUIDED PROCEDURES SEGMENT TO ACCOUNT FOR A SMALLER SHARE OF THE MARKET
TABLE 36 ASPIRATION AND BIOPSY NEEDLES MARKET FOR NON-IMAGE-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION)
8 ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 37 ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
8.2 TUMOR/CANCER APPLICATIONS
TABLE 38 ASPIRATION AND BIOPSY NEEDLES MARKET FOR TUMOR/CANCER APPLICATIONS, BY TYPE, 2019–2027 (USD MILLION)
8.2.1 BREAST CANCER
8.2.1.1 Increasing awareness of breast cancer to drive the growth of this market segment
TABLE 39 ASPIRATION AND BIOPSY NEEDLES MARKET FOR BREAST CANCER, BY REGION, 2019–2027 (USD MILLION)
8.2.2 LUNG CANCER
8.2.2.1 Growing prevalence of lung cancer to support the growth of this market segment
TABLE 40 ASPIRATION AND BIOPSY NEEDLES MARKET FOR LUNG CANCER, BY REGION, 2019–2027 (USD MILLION)
8.2.3 COLORECTAL CANCER
8.2.3.1 Advancements in alternative diagnosis techniques to reduce
the adoption of colorectal biopsy needles
TABLE 41 ASPIRATION AND BIOPSY NEEDLES MARKET FOR COLORECTAL CANCER, BY REGION, 2019–2027 (USD MILLION)
8.2.4 PROSTATE CANCER
8.2.4.1 Availability of funds for prostate cancer research by different government authorities to support the growth of this market segment
TABLE 42 ASPIRATION AND BIOPSY NEEDLES MARKET FOR PROSTATE CANCER, BY REGION, 2019–2027 (USD MILLION)
8.2.5 KIDNEY CANCER
8.2.5.1 Rising prevalence of kidney cancer to support the growth of this market segment
TABLE 43 ASPIRATION AND BIOPSY NEEDLES MARKET FOR KIDNEY CANCER, BY REGION, 2019–2027 (USD MILLION)
8.2.6 BONE & BONE MARROW CANCER
8.2.6.1 Rising incidence of bone cancer to fuel the growth of this market segment
TABLE 44 ASPIRATION AND BIOPSY NEEDLES MARKET FOR BONE & BONE MARROW CANCER, BY REGION, 2019–2027 (USD MILLION)
8.2.7 OTHER CANCERS
TABLE 45 ASPIRATION AND BIOPSY NEEDLES MARKET FOR OTHER CANCERS, BY REGION, 2019–2027 (USD MILLION)
8.3 WOUND APPLICATIONS
8.3.1 THE DEMAND FOR WOUND BIOPSIES IS EXPECTED TO INCREASE WITH
THE INCREASE IN PREVALENCE OF DIABETIC FOOT ULCERS
TABLE 46 ASPIRATION AND BIOPSY NEEDLES MARKET FOR WOUND APPLICATIONS, BY REGION, 2019–2027 (USD MILLION)
8.4 OTHER APPLICATIONS
TABLE 47 ASPIRATION AND BIOPSY NEEDLES MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2027 (USD MILLION)
9 ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER
9.1 INTRODUCTION
TABLE 48 ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
9.2 HOSPITALS & SURGICAL CENTERS
9.2.1 HOSPITALS AND SURGICAL CENTERS ARE THE LARGEST END USERS OF ASPIRATION AND BIOPSY NEEDLES
TABLE 49 ASPIRATION AND BIOPSY NEEDLES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2019–2027 (USD MILLION)
9.3 AMBULATORY CARE CENTERS
9.3.1 PREFERENCE FOR NEEDLE BIOPSIES IN AMBULATORY CARE CENTERS IS INCREASING DUE TO ONE-DAY OUTPATIENT SURGERY TIMELINES
TABLE 50 ASPIRATION AND BIOPSY NEEDLES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2019–2027 (USD MILLION)
9.4 DIAGNOSTIC CLINICS & PATHOLOGY LABORATORIES
9.4.1 A MAJORITY OF SAMPLE DIAGNOSIS IS PERFORMED BY DIAGNOSTIC/PATHOLOGY LABORATORIES
TABLE 51 ASPIRATION AND BIOPSY NEEDLES MARKET FOR DIAGNOSTIC CLINICS & PATHOLOGY LABORATORIES, BY REGION, 2019–2027 (USD MILLION)
9.5 RESEARCH & ACADEMIC INSTITUTES
9.5.1 MARKET FOR BIOPSY NEEDLES IN RESEARCH & ACADEMIC INSTITUTES IS EXPECTED TO GROW WITH GROWTH IN CANCER RESEARCH
TABLE 52 ASPIRATION AND BIOPSY NEEDLES MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2019–2027 (USD MILLION)
10 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION
10.1 INTRODUCTION
TABLE 53 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION)
10.2 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT
TABLE 54 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 55 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 56 ASIA PACIFIC: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 57 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 58 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 59 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
10.2.1 CHINA
10.2.1.1 China is the largest market for aspiration and biopsy needles in APAC
TABLE 60 CHINA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 61 CHINA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.2.2 JAPAN
10.2.2.1 Japan is the second-largest market for aspiration and biopsy needles in APAC
TABLE 62 JAPAN: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 63 JAPAN: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.2.3 INDIA
10.2.3.1 Improving healthcare infrastructure to drive market growth in India
TABLE 64 INDIA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 65 INDIA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.2.4 SOUTH KOREA
10.2.4.1 Growing healthcare expenditure to drive market growth in
South Korea
TABLE 66 SOUTH KOREA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 67 SOUTH KOREA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.2.5 AUSTRALIA
10.2.5.1 Increasing prevalence of cancer to drive market growth in Australia
TABLE 68 AUSTRALIA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 69 AUSTRALIA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.2.6 REST OF ASIA PACIFIC
TABLE 70 ROAPAC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 71 ROAPAC: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.3 EUROPE
TABLE 72 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 73 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 74 EUROPE: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 75 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 76 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 77 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Higher per capita spending on healthcare and presence of notable players to drive market growth in Germany
TABLE 78 GERMANY: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 79 GERMANY: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 Increasing prevalence of cancer to drive market growth in France
TABLE 80 FRANCE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 81 FRANCE: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.3.3 UK
10.3.3.1 Higher per capita spending on healthcare and the presence of notable players are expected to support market growth in the UK
TABLE 82 UK: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 83 UK: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Increasing geriatric population to drive market growth in Italy
TABLE 84 ITALY: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 85 ITALY: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Growing prevalence of cancer to drive market growth in Spain
TABLE 86 SPAIN: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 87 SPAIN: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 88 ROE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 89 ROE: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.4 NORTH AMERICA
FIGURE 29 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT
TABLE 90 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 91 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 92 NORTH AMERICA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 93 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 94 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 95 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
10.4.1 US
10.4.1.1 The US dominates the North American aspiration and biopsy needles market
TABLE 96 US: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 97 US: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.4.2 CANADA
10.4.2.1 Growing incidence of cancer to drive market growth in Canada
TABLE 98 CANADA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 99 CANADA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.5 LATIN AMERICA
TABLE 100 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 101 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 102 LATIN AMERICA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 103 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 104 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 105 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Brazil is the largest market for aspiration and biopsy needles
in LATAM
TABLE 106 BRAZIL: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 107 BRAZIL: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Increasing healthcare spending to drive market growth in Mexico
TABLE 108 MEXICO: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 109 MEXICO: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 110 ROLA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 111 ROLA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH IN MEA
TABLE 112 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
TABLE 113 MIDDLE EAST & AFRICA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 114 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
TABLE 115 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
TABLE 116 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES
11.3 MARKET SHARE ANALYSIS: ASPIRATION AND BIOPSY NEEDLES MARKET, BY KEY PLAYER (2020)
FIGURE 30 BECTON, DICKINSON AND COMPANY HELD THE LEADING POSITION IN
THE ASPIRATION AND BIOPSY NEEDLES MARKET IN 2020
11.4 COMPANY EVALUATION QUADRANT FOR 25 MAJOR PLAYERS (2020)
11.4.1 STARS
11.4.2 EMERGING LEADERS
11.4.3 PERVASIVE PLAYERS
11.4.4 PARTICIPANTS
FIGURE 31 ASPIRATION AND BIOPSY NEEDLES MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
11.5 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2020)
11.5.1 PROGRESSIVE COMPANIES
11.5.2 RESPONSIVE COMPANIES
11.5.3 DYNAMIC COMPANIES
11.5.4 STARTING BLOCKS
FIGURE 32 ASPIRATION AND BIOPSY NEEDLES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS (2020)
11.6 COMPETITIVE BENCHMARKING
TABLE 117 APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ASPIRATION AND BIOPSY NEEDLES MARKET
TABLE 118 REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ASPIRATION AND BIOPSY NEEDLES MARKET
11.7 COMPETITIVE SCENARIO (2018–2021)
11.7.1 NEW PRODUCT LAUNCHES AND APPROVALS
11.7.2 DEALS
12 COMPANY PROFILES
12.1 INTRODUCTION
12.2 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.2.1 BECTON, DICKINSON AND COMPANY (BD)
TABLE 119 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 33 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
12.2.2 MERIT MEDICAL SYSTEMS
TABLE 120 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW
FIGURE 34 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2020)
12.2.3 COOK GROUP INCORPORATED
TABLE 121 COOK GROUP INCORPORATED: BUSINESS OVERVIEW
12.2.4 OLYMPUS CORPORATION
TABLE 122 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 35 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021)
12.2.5 MEDTRONIC, PLC
TABLE 123 MEDTRONIC, PLC: BUSINESS OVERVIEW
FIGURE 36 MEDTRONIC, PLC: COMPANY SNAPSHOT (2020)
12.2.6 ARGON MEDICAL DEVICES, INC.
TABLE 124 ARGON MEDICAL DEVICES, INC: BUSINESS OVERVIEW
12.2.7 BOSTON SCIENTIFIC CORPORATION
TABLE 125 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 37 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)
12.2.8 CARDINAL HEALTH, INC.
TABLE 126 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
FIGURE 38 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2021)
12.2.9 CONMED CORPORATION
TABLE 127 CONMED CORPORATION: BUSINESS OVERVIEW
FIGURE 39 CONMED CORPORATION: COMPANY SNAPSHOT (2020)
12.2.10 HAKKO CO., LTD.
TABLE 128 HAKKO CO., LTD.: BUSINESS OVERVIEW
12.2.11 INRAD INC.
TABLE 129 INRAD INC.: BUSINESS OVERVIEW
12.2.12 RANFAC CORPORATION
TABLE 130 RANFAC CORPORATION: BUSINESS OVERVIEW
12.2.13 REMINGTON MEDICAL INC.
TABLE 131 REMINGTON MEDICAL INC.: BUSINESS OVERVIEW
12.2.14 SOMATEX MEDICAL TECHNOLOGIES
TABLE 132 SOMATEX MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW
12.2.15 STRYKER CORPORATION
TABLE 133 STRYKER CORPORATION: BUSINESS OVERVIEW
FIGURE 40 STRYKER CORPORATION: COMPANY SNAPSHOT (2020)
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.3 OTHER PLAYERS
12.3.1 CREGANNA
12.3.2 STERYLAB SRL
12.3.3 DR. JAPAN CO., LTD.
12.3.4 DTR MEDICAL
12.3.5 ISCON SURGICALS LTD.
12.3.6 JOHNSON & JOHNSON MEDICAL DEVICES
12.3.7 SHANGHAI SA MEDICAL & PLASTIC INSTRUMENTS
12.3.8 MEDAX MEDICAL DEVICES
12.3.9 MEDITECH DEVICES
12.3.10 WELLGO MEDICAL PRODUCTS GMBH
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
